A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
04/27/2015 | Roisin McGuigan
Diagnosing neurodegenerative diseases like Alzheimer’s can be a hit and miss process – but is a lab-based test on the horizon?
03/31/2015 | Fedra Pavlou
Scent-trained dogs sniff out cancer. Whatever next?
03/30/2015 | Marc Denis
Overcoming limitations of an established standard by unlocking molecular biomarkers in body fluids
03/30/2015 | Roisin McGuigan
Targeted biopsies for prostate cancer could increase detection of high risk disease and help to prevent over-diagnosis
03/30/2015 | Fedra Pavlou
Protein biomarkers identified using mass spec analysis of saliva could pave the way for earlier, more reliable diagnosis
03/29/2015 | Jeremy Nicholson, Ron M. A. Heeren, Steven Olde Damink
Jeremy Nicholson shares the vision behind the UK’s MRC-NIHR National Phenome Centre, Ron Heeren showcases the new M4I institute and Steven Olde Damink offers the surgeon’s perspective as a new age of healthcare dawns.
03/03/2015 | Udo Margraff
Infectious disease diagnostics keep improving, but which methods should you focus on?
03/03/2015 | Dror Fixler
A new, noninvasive approach to cancer imaging uses gold nanorods and reflected light to detect even small tumors
03/03/2015 | R. Condon Hughes, III
Optical biopsy could provide a wide range of diagnoses in minutes and should be viewed as a support, not a threat, to pathologists
01/30/2015 | Roisin McGuigan
Prostate-specific antigen (PSA) assay: essential part of prostate cancer diagnosis or public menace? We fire up the discussion with five expert views.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Genetic Counseling
The Future Lies in Phenomic Medicine
Trusted Bodies for PGx